InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+5.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by REESE DAVID M, Vice-Président Exécutif, Recherche et Développement. Officer active across 1 company, notably AMGEN INC. Cumulatively, 31 filings have been published. Activity tracked since 30 April 2021. The latest transaction was filed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations31 total
746 shares@ US$329.820.0001% mcap2.3% of flowCommon StockSEC:0000318154-26-000067:0
687 shares@ US$329.820.0001% mcap2.1% of flowCommon StockSEC:0000318154-26-000067:1
3,549 shares0Common StockSEC:0001127602-25-013786:0
702 shares@ US$283.781.9% of flowCommon StockSEC:0001127602-25-013533:0
665 shares@ US$283.781.8% of flowCommon StockSEC:0001127602-25-013533:1
768 shares@ US$288.562.1% of flowCommon StockSEC:0001127602-25-013286:0
3,635 shares@ US$313.7111.4% of flowCommon StockSEC:0001127602-25-010060:0
7,277 shares0Common StockSEC:0001127602-25-008428:0
8,711 shares@ US$156.3514.2% of flowCommon StockSEC:0001127602-25-006282:0
3,196 shares0Common StockSEC:0001127602-24-014858:0
633 shares@ US$311.292.0% of flowCommon StockSEC:0001127602-24-014512:0
650 shares@ US$277.371.8% of flowCommon StockSEC:0001127602-24-014196:0
690 shares@ US$276.381.9% of flowCommon StockSEC:0001127602-24-013813:0
6,202 shares@ US$268.8716.6% of flowCommon StockSEC:0001127602-24-010858:0
12,407 shares0Common StockSEC:0001127602-24-009247:0
165 shares0Common StockSEC:0001127602-23-028437:0
594 shares@ US$231.891.4% of flowCommon StockSEC:0001127602-23-015051:0
3,814 shares0Common StockSEC:0001127602-23-014612:0
666 shares@ US$239.741.6% of flowCommon StockSEC:0001127602-23-014157:0
3,978 shares@ US$234.579.6% of flowCommon StockSEC:0001127602-23-010922:0
7,947 shares0Common StockSEC:0001127602-23-009495:0
2,440 shares@ US$272.067.3% of flowCommon StockSEC:0001127602-22-024930:0
575 shares@ US$236.100.0001% mcap6.4% of flowCommon StockSEC:0001127602-22-013876:0
3,897 shares0Common StockSEC:0001127602-22-013352:0
184 shares@ US$249.870.0000% mcap2.1% of flowCommon StockSEC:0001127602-22-012766:0
25 of 31 declarations
About REESE DAVID M
David M. Reese is the EVP, Research and Development at AMGEN INC. In this role, he is responsible for leading the company's research and development initiatives. David brings scientific and strategic expertise, thereby contributing to innovation and advancing research projects.
